WHAT'S NEW

"Researchers from the University of Iowa recently discovered that “patients diagnosed with an autism spectrum disorder (ASD) have more cancer-promoting oncogenes but lower rates of cancer.” DNA variations play a major role in both aspects. http://ow.ly/4n4Icb - 22 hours ago via Facebook
"Research has found that patients diagnosed w/ autism have more cancer-promoting oncogenes but lower rates of cancer. https://t.co/HvaMxqvPfE - 1 day ago via Twitter
"The National Cancer Moonshot Initiative announced by Vice President Joe Biden earlier this year is looking for ideas. Members of the research community, and also the general public are encouraged to submit ideas for the effort. Areas could range from clinical trials to immunotherapy to pediatric cancer. Learn more at: http://ow.ly/4n4I1q - 3 days ago via Facebook
"The National Cancer Moonshot Initiative is looking for people to submit ideas for the effort. Learn more at: https://t.co/SRJxebxGfM - 3 days ago via Twitter
"A recent study analyzed the impact of the anti-VEGF antibody bevacizumab in patients with relapsed glioblastoma- a form of primitive brain tumor. One finding was that bevacizumab combined with irinotecan is effective in relapsed glioblastoma with acceptable toxicity. http://ow.ly/4n4HV2 - 4 days ago via Facebook
"A study found that bevacizumab combined w/ irinotecan is effective in relapsed glioblastoma with acceptable toxicity https://t.co/CX7PCu5yjF - 4 days ago via Twitter
"New evidence finds that cannabis can cut tumor growth in half! Researchers predict that “THC had such a positive effect on combating tumors because it activates molecules that arrest the cell cycle, and may also interfere with the processes of angiogenesis and vascularization, which lead to cancer growth.” http://ow.ly/4mUaZX - 1 week ago via Facebook
"New evidence finds that cannabis can cut tumor growth in half & may also interfere with the process of angiogenesis https://t.co/rXrfn67pKA - 1 week ago via Twitter
"A new test, known as a “liquid biopsy” blood test, is said to help guide doctors into choosing the best drugs for treating their lung cancer patients. http://ow.ly/4mUaS1 - 1 week ago via Facebook
"The new “liquid biopsy” blood test is said to help doctors choose the best drugs for treating lung cancer patients. https://t.co/xqUKwdsQd5 - 1 week ago via Twitter
"A phase II randomized trial found that adding the angiogenesis inhibitor bevacizumab to a short course of androgen deprivation therapy improved relapse-free survival in men with hormone-sensitive prostate cancer. http://ow.ly/10y0Sp - 2 weeks ago via Facebook
"A phase II trial found that adding bevacizumab to ADT improved relapse-free survival in men with prostate cancer. https://t.co/qaVbfX4UZB - 2 weeks ago via Twitter
"The 2016 Ross Prize in Molecular Medicine: Resolution of Inflammation will honor Charles N Serhan, PhD, Dsc, of Brigham & Women’s Hospital and Harvard Medical School. At this meeting, Dr. Serhan will speak about his work on critical factors in resolving infectious inflammation & tissue regeneration. Register for the June 13th event today! bit.nyas.org/1KsgYBG - 2 weeks ago via Facebook
"Researchers found that higher levels of vitamin D are linked to a reduced risk of cancer. A blood test is the only accurate measure of vitamin D levels and after combining results from a randomized clinical trial of 1,169 women and a prospective cohort study of 1,135 women, findings show that levels of 40ng/ml or higher had a 67 percent lower risk for cancer. http://ow.ly/10y0Y7 - 2 weeks ago via Facebook
"Researchers found that those with higher levels of vitamin D (40ng/ml+) had a 67 percent lower risk for cancer. https://t.co/lUCSsb3YEC - 2 weeks ago via Twitter
"Designing new cancer therapies that block both angiogenesis and vessel co-option could avoid chemoresistance. https://t.co/iVJF61QLyT - 3 weeks ago via Twitter
"During a recent study, researchers report that tumors can become resistant to antiangiogenic drugs over time by learning to steal normal blood vessels from surrounding tissue. The researchers say that it could be an option to treat cancers by designing new therapies that block both angiogenesis and vessel co-option to avoid this chemoresistance. This study may have implications for liver, metastatic breast, and metastatic bowel cancers. http://www.genengnews.com/gen-news-highlights/new-approach-shows-promise-for-overcoming-chemoresistance/81252586/ - 3 weeks ago via Facebook
"Carrots are often linked to eye health, but did you know that eating them could also reduce the risk of breast cancer? Recent studies have linked women with higher blood concentrations of carotenoids to reduced breast cancer risk, specifically those that are estrogen receptor negative. http://ow.ly/10jV6s - 3 weeks ago via Facebook
"Carrots are often linked to eye care, but did you know that eating them could also reduce the risk of breast cancer? https://t.co/8Jv1JZKAZZ - 3 weeks ago via Twitter
"It’s World Health Day! This year the World Health Organization has chosen to focus on diabetes as it is becoming an increasingly larger health threat worldwide. - 3 weeks ago via Facebook
"It's World Health Day! In 2016 the focus is on diabetes as it is becoming an increasingly larger world health threat https://t.co/SVolSHfSP5 - 3 weeks ago via Twitter
The FDA has approved Afinitor (everolimus) for the treatment of adult patients with progressive, well-differentiated non-functional, locally advanced Read More >
Inaugural World Summit on Food and Health in Paris Convened Innovative Thinkers from Science, Medicine, Culinary, Technology, and Aerospace Fields to Read More >
The U. S. Food and Drug Administration approved ramucirumab for use in combination with FOLFIRI for the treatment of patients with metastatic colorect Read More >
Dr. William Li, President and Medical Director of the Angiogenesis Foundation, gave the keynote address at the Read More >
The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with Read More >
The U.S. Food and Drug Administration (FDA) has approved lenvatinib (Lenvima) to treat patients with progressive, differentiated thyroid cancer (DTC) Read More >
The European Union's (EU) Committee for Medicinal Products for Human Use (CHMP) has recommended the use of bevacizumab (Avastin) in combination with s Read More >
Anti-VEGF agent aflibercept (EYLEA®) has been approved by the European Commission for the treatment of visual impairment due to Macular Edema seconda Read More >
Dr. William Li Featured on The Dr. Oz Show

What does luck have to do with cancer? A recently published Read More >
The U.S. Food and Drug Administration today expanded the approved use for ranibizumab injection 0.3 mg (Lucentis) to treat diabetic retinopathy (DR) i Read More >
Lenvatinib, an oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, fibroblast growth factor receptors 1 through 4, platelet-de Read More >

ANGIO LIFE

Dr. Li shares 22 Cancer Fighting Tips with Dr. Oz

Dr. William Li joins Dr. Oz to share 22 ways to cut your risk of cancer risk by 50 percent. Read More >

Dr. William Li presents at TED

Dr. William Li presents “Can we eat to starve cancer?” at TED 2010 in Long Beach, CA. Read More >

 

IN THE MEDIA

Screen Shot 2016-02-12 at 4.15.51 PM

Ultimate Food Fight: The Angiogenesis Foundation’s Declaration of War on Cancer and Other Non-Communicable Diseases Using Diet. Read More

4744.Reuters-Logo

October 8, 2015: The non-profit Angiogenesis Foundation today launched a nationwide multimedia campaign EyeCanDoIt as their contribution to World Sight Day. Read More >

CNW_Logo

September 16, 2015: L’Angiogenesis Foundation a publié un livre blanc aujourd’hui qui aborde les besoins, les défis, ainsi que les solutions proposées au Canada pour la prévention de la perte de vision chez les diabétiques. Read More >

NPR Marketplace logo

November 6, 2014: For the second consecutive year, the Angiogenesis Foundation has received the highest rating from Charity Navigator, the prominent independent evaluator of charities. Read More >

DoctorOZ-1

May 20, 2014: “The Dr. Oz Show” features Dr. William Li who shares 3 all-natural breakthroughs that can reduce your risk of cancer. Read More >

marketwatch-logo

April 23, 2014: The Bates-Jensen Wound Reach Foundation and the Angiogenesis Foundation announce Keith Brantly will run in the Wound Reach Foundation OUCH! Race. Read More >

DoctorOZ (1)

February 7, 2014: Dr. William Li appears on “The Dr. Oz Show” to share 22 ways to cut your cancer risk by 50%. Read More >

yahoo-news-logo

January 21, 2014: The Angiogenesis Foundation, in collaboration with musician / activist Peter Gabriel, has launched the Do iT Yourself Health Revolution Read More >

yahoo-news-logo

November 7, 2013: The Angiogenesis Foundation receives highest rating from Charity Navigator, a premiere charity evaluator, for good governance, fiscal management, accountability and transparency. Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Launches Multimedia Campaigns for Saving Vision at the 13th Euretina Congress Read More >

bostoncomlogo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer at the European Cancer Congress 2013 Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Advancing Treatment of Wet Age-Related Macular Degeneration at the 13th Euretina Congress Read More >

WSJ-Logo2

July 16, 2013: The Angiogenesis Foundation Presents Concept of Antiangiogenic Foods at IFT 2013 Annual Meeting + Food Expo Read More >

usatoday_logo

June 4, 2013: Dr. William Li discusses the impact of drug shortages for cancer patients in USA Today. Read More >

usatoday_logo

June 3, 2013: Dr. William Li discusses recent developments for patients with metastatic thyroid cancer in USA Today. Read More >

HEAR FROM THE EXPERTS

   

The “Best of Antiangiogenesis” is a series of webcasts, generated through Project ENABLE™, featuring presentations from leading medical experts describing research and perspectives on new angiogenesis-based therapies.

To view additional webcasts, click here
 

LEARN ABOUT DISEASE TREATMENTS

PUBLICATIONS

GREEN TEA

Our tea research is part of our Eat to Beat Cancer initiative, which is setting out to find foods and beverages that restore balance to the body's angiogenesis system. By purchasing this tea you are supporting our research and helping to advance the frontiers of cancer prevention.